Post-approval studies (Phase 4)Study completedNCT00226382
What this trial is testing
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment
Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 50